Polyethylene glycol-phosphatidylethanolamine (PEG-PE)/vitamin E micelles for co-delivery of paclitaxel and curcumin to overcome multi-drug resistance in ovarian cancer.
about
Multifunctional polymeric micelles for delivery of drugs and siRNA.Identification of epithelial ovarian tumor-specific aptamers.Curcumin delivered through bovine serum albumin/polysaccharides multilayered microcapsules.Codelivery of SH-aspirin and curcumin by mPEG-PLGA nanoparticles enhanced antitumor activity by inducing mitochondrial apoptosis.Preparation, characterization, in vivo pharmacokinetics, and biodistribution of polymeric micellar dimethoxycurcumin for tumor targeting.Applications of nanoparticle drug delivery systems for the reversal of multidrug resistance in cancer.Dual Drug Loaded Biodegradable Nanofibrous Microsphere for Improving Anti-Colon Cancer Activity.Progress in nanotechnology-based drug carrier in designing of curcumin nanomedicines for cancer therapy: current state-of-the-art.Curcumin suppresses cisplatin resistance development partly via modulating extracellular vesicle-mediated transfer of MEG3 and miR-214 in ovarian cancer.Development and evaluation of vitamin E d-α-tocopheryl polyethylene glycol 1000 succinate-mixed polymeric phospholipid micelles of berberine as an anticancer nanopharmaceutical.Current trends in the use of vitamin E-based micellar nanocarriers for anticancer drug delivery.Quality-of-life outcomes in patients with gynecologic cancer referred to integrative oncology treatment during chemotherapy.Co-Delivery of Drugs and Genes Using Polymeric Nanoparticles for Synergistic Cancer Therapeutic Effects.Co-delivery nanoparticles of anti-cancer drugs for improving chemotherapy efficacy.In vitro and in vivo study of Baicalin-loaded mixed micelles for oral delivery.
P2860
Q30438973-27BE8A0F-7E51-4E20-B7F4-A147C1A08C3CQ35635298-9B4C9E93-1D44-44FD-89E8-292F3EF75F3EQ35767247-9CF1F2B8-20BE-4048-ACA9-E169837597CCQ35991005-0793D32D-258E-4EF5-B664-3389366D828FQ36160393-9F28512A-81E2-4916-BCCD-ABA9D49F850CQ37002153-A5DFC8C0-9955-4897-9493-9ED3168B3CD7Q37023985-439E733E-79EA-4B81-B42A-2736C89F3160Q38525432-6E474E9D-504B-450E-B217-1F3814C26564Q38717405-4CAAEB7A-BC90-4260-8C14-10CF19438169Q38768934-BEB68871-EFEC-473D-9399-7347CC1CD479Q38937032-B498D924-B125-4C45-986A-C3F09ED2F161Q41264599-B48FEF5B-D83A-473A-8139-8B9DE86A9B34Q47642768-32E7253B-0620-4FAE-BC8B-64BF1599494DQ47808831-C6387986-ED29-48B0-8910-D2C3AC06A7C0Q53604584-E9BAC50A-5136-4E4E-A1B7-5E4D922E2DF1
P2860
Polyethylene glycol-phosphatidylethanolamine (PEG-PE)/vitamin E micelles for co-delivery of paclitaxel and curcumin to overcome multi-drug resistance in ovarian cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Polyethylene glycol-phosphatid ...... resistance in ovarian cancer.
@en
Polyethylene glycol-phosphatidylethanolamine
@nl
type
label
Polyethylene glycol-phosphatid ...... resistance in ovarian cancer.
@en
Polyethylene glycol-phosphatidylethanolamine
@nl
prefLabel
Polyethylene glycol-phosphatid ...... resistance in ovarian cancer.
@en
Polyethylene glycol-phosphatidylethanolamine
@nl
P2093
P2860
P921
P1476
Polyethylene glycol-phosphatid ...... resistance in ovarian cancer.
@en
P2093
Abraham H Abouzeid
Niravkumar R Patel
Vladimir P Torchilin
P2860
P304
P356
10.1016/J.IJPHARM.2014.01.009
P407
P577
2014-01-17T00:00:00Z